FDA Enforcement Initiatives Raise Visibility Of Supply Chain GMP Issues
Executive Summary
US FDA is issuing “90-day” decisional letters at a quickening pace, publishing the inspectional results within another 30 days, and copying sponsors on warning letters, among other steps, to call their attention to GMP problems in their supply chains.